Dr Colin Story
InvestorAdvisory Board Member at UK Innovation & Science Seed Fund
Find your path to Dr Colin Story
25 people in our graph share verified history with Dr Colin Story — schools, employers, funds. One of them is your warm intro.
About
Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.
Invests in
BiotechMedical Devices
Investments
Board seats
BetaGlue Technologies SpAHox Therapeutics Limited
Per the firm's website.
Colleagues at UK Innovation & Science Seed Fund
Frequently asked questions
- Who is Dr Colin Story?
- Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.
- Where does Dr Colin Story work?
- Dr Colin Story is Advisory Board Member at UK Innovation & Science Seed Fund.
- What does Dr Colin Story invest in?
- Dr Colin Story invests in Biotech, Medical Devices.
- What boards does Dr Colin Story sit on?
- Dr Colin Story holds tracked board seats at BetaGlue Technologies SpA, Hox Therapeutics Limited.